Department of Neurology, Xuan Wu Hospital of the Capital Medical University, and Neurodegenerative Laboratory of Ministry of Education of the People's Republic of China, Beijing, China.
Aging Cell. 2011 Aug;10(4):711-9. doi: 10.1111/j.1474-9726.2011.00708.x. Epub 2011 May 3.
We previously described an association between Alzheimer's disease (AD) and a single-nucleotide polymorphism -980C/G (rs3754048) in the promoter of the anterior pharynx-defective-1a (APH-1A) gene. Here, we examine the potential of this -980C/G polymorphism to affect APH-1A transcription and confer a risk of AD. We validated the presence of APH-1A promoter polymorphism -980C/G in other two Chinese cohort sets (450 AD and 450 controls). Subsequently, we measured APH-1A mRNA and protein levels and γ-secretase activity in C or G allele carriers. Finally, we examined the polymorphism's transcriptional function using a dual-luciferase reporter assay and also tracked transcription factor binding to the variant promoter sequence with electrophoretic mobility shift assays (EMSAs). We found that the APH-1A levels and γ-secretase activity were higher in individuals carrying allele G. The G allele increased APH-1A transcriptional activity significantly in both N2A cells and HEK293 cells. The EMSA revealed an increased binding of the transcription factor Yin Yang 1 (YY1) to allele G. Overexpression of YY1 resulted in an activation of the APH-1A promoter (2.7-fold). Specific YY1 siRNA led to decreases in APH-1A promoter activity and mRNA and protein levels. Our data indicate that the APH-1A promoter polymorphism -980C/G might alter the binding ability of YY1 transcription factor, resulting in an increased level of APH-1A and γ-secretase activity. These factors further facilitated β-amyloid (Aβ) 42 generation and ultimately modified patients' susceptibility to AD. The involvement of transcription factor YY1 might be a novel mechanism for the development of AD.
我们之前描述了阿尔茨海默病(AD)与前咽缺陷 1a(APH-1A)基因启动子中单核苷酸多态性-980C/G(rs3754048)之间的关联。在这里,我们研究了这种-980C/G 多态性是否会影响 APH-1A 转录并导致 AD 风险。我们在另外两个中国队列(450 例 AD 和 450 例对照)中验证了 APH-1A 启动子多态性-980C/G 的存在。随后,我们测量了 C 或 G 等位基因携带者的 APH-1A mRNA 和蛋白水平以及 γ-分泌酶活性。最后,我们使用双荧光素酶报告基因检测法检查了该多态性的转录功能,并用电泳迁移率变动分析(EMSA)法跟踪了转录因子与变体启动子序列的结合。我们发现,携带等位基因 G 的个体的 APH-1A 水平和 γ-分泌酶活性较高。该等位基因显著增加了 N2A 细胞和 HEK293 细胞中 APH-1A 的转录活性。EMSA 显示转录因子 Yin Yang 1(YY1)与等位基因 G 的结合增加。YY1 的过表达导致 APH-1A 启动子激活(2.7 倍)。特异性 YY1 siRNA 导致 APH-1A 启动子活性以及 mRNA 和蛋白水平降低。我们的数据表明,APH-1A 启动子多态性-980C/G 可能改变 YY1 转录因子的结合能力,导致 APH-1A 和 γ-分泌酶活性增加。这些因素进一步促进了β-淀粉样蛋白(Aβ)42 的产生,并最终改变了患者对 AD 的易感性。转录因子 YY1 的参与可能是 AD 发展的新机制。